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Abstract
The CDKN2A locus encodes two important tumor suppressors, INK4a and ARF, which respond to oncogenic stresses by
inducing cellular senescence. We conducted a genome-scale cDNA overexpression screen using a reporter containing INK4a
regulatory sequences to identify novel transcriptional activators of this locus. This screen revealed 285 cDNAs that putatively
regulate the transcriptional activation of INK4a. Of these, 56 are annotated as transcription factors, including two previously
reported activators of the locus, ETS2 and JUNB. Fourteen genes were further validated for activity and specificity, including
several homeodomain proteins. We found that the transcription of one of these, the homeodomain protein MEOX2 (GAX) is
enhanced in primary cells during the induction of senescence, and forced expression of this protein results in the induction
of premature senescence. We further demonstrate that MEOX2-induced senescence is dependent upon INK4a activity, and
chromatin immunoprecipitation studies indicate that MEOX2 directly binds the INK4a promoter. These results support a role
for this homeodomain protein as a direct regulator of INK4a transcription and senescence in human cells.
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Introduction
The human CDKN2A locus encodes two important tumor
suppressors, p16INK4a and p14ARF. This locus was initially
discovered due to its linkage with a familial melanoma
susceptibility syndrome, and subsequent work has demonstrated
frequent loss of functionality of one or both of these genes in a
wide variety of sporadic tumors (reviewed in [1]). Mouse models
which harbor deletions in either or both genes reveal that,
although neither is essential for embryonic development, both are
involved in suppressing various tumor types (reviewed in [2]).
INK4a and ARF are completely nonhomologous proteins, with
distinct biochemical functions, yet the transcription of both genes
increases in response to similar signals, resulting in an exit from the
cell cycle (reviewed in [3]). Transcription of INK4a and ARF is
driven by unrelated promoter sequences located 13 kb apart;
distinct first exons for each gene are spliced to shared second and
third exons that are translated in different open reading frames.
The resulting INK4a gene product is a direct inhibitor of cyclin-
dependent kinases 4 and 6. By preventing their interactions with
D-type cyclins, INK4a prevents CDK 4/6 phosphorylation of RB.
In the absence of CDK4/6 phosphorylation, RB remains bound to
E2F1, thereby preventing E2F1 dependent transcription of S
phase initiating functions. In contrast, the ARF gene product
prevents MDM2-mediated polyubiquitination of p53, thereby
inhibiting its proteasomal degradation. The resulting increase of
p53 levels in the nucleus results in G1 arrest primarily through
increased transcription of the CDK inhibitor p21CIP1.
Interestingly, both the INK4a-Rb and ARF-p53 pathways
have also been implicated in the phenomenon of cellular
senescence, wherein cultured primary cells exhibit progressive
loss of proliferative capacity during passaging. This loss of
proliferative potential occurs by activation of a differentiation-
like program that causes stochastic G1 arrest, and is accompa-
nied by characteristic morphological changes (reviewed in [4]).
The senescence program is activated by a variety of signals,
including progressive loss of telomeric sequences during repeated
rounds of DNA replication, other forms of DNA damage, and
the oxidative and nutritional deficiencies present under tissue
culture conditions. It is likely that all of these intra- and
extracellular stresses are present at various stages of tumorigen-
esis. In fact, similar underlying signaling events have been shown
to regulate both cellular senescence and in vivo tumorigenesis. For
example, cellular senescence can be triggered by overexpression
of some oncogenes, including activated RAS. The induction of
this has been shown to result in INK4a activation through the
RAF/MEK/ERK kinase cascade-mediated activation of Ets
family transcription factors [5]. Senescence has also been
observed in preneoplastic lesions in vivo,a sw e l la si nt u m o r so f
patients treated with certain chemotherapeutic agents [6–9].
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5067Thus, INK4a and ARF are key regulators of a cell-autonomous
surveillance system that responds to oncogenic signals by
triggering a program that results in exit from the cell cycle.
In addition, these pathways have been implicated as negative
regulators of stem cell self-renewal capacity, suggesting a role for
these proteins in maintaining a balance between suppression of
tumor cell growth and promotion of self-renewal of healthy tissues
[10]. For example, BMI1 is both a proto-oncogene and a key
regulator of stem cell self-renewal capacity, and exerts much of this
control through suppression of INK4a and ARF expression
[11,12].
Here we present an unbiased, genome-scale functional screen to
identify regulators of INK4a. We report the identification of 14
proteins that robustly and specifically activate transcription
through INK4a regulatory sequences, and demonstrate a role
for one regulator, MEOX2, in the regulation of senescence
through direct transcriptional activation of p16INK4a.
Results and Discussion
Functional screen for potential activators of INK4a
We conducted a genome-wide functional screen using an
arrayed cDNA library to identify transcriptional activators of
INK4a. We first constructed a luciferase-based reporter harboring
transcriptional regulatory sequences located upstream of the
INK4a coding region (Fig. 1a, top) [5,13]. This construct was
validated by cotransfection with the known INK4a activator
ETS2, which resulted in 4–5 fold activation of the reporter (Fig. 1a,
middle) [5,13]. We then employed a cDNA library consisting of
approximately 15,000 arrayed full-length human cDNAs to
identify activators of this reporter by transient cotransfection in
U2OS osteosarcoma cells (Fig. 1a, bottom). Importantly, U2OS
cells are deficient in INK4a expression due to methylation of the
promoter sequences [14], and thus are resistant to induction of
senescence by overexpression of cDNAs that activate transcription
of INK4a. Analysis of duplicate genome-wide screens revealed 285
potential activators by the criterion of increasing luciferase
expression by 2.5 fold or higher over each plate mean (Fig. 1b
and Table S1). These include several known or anticipated
activators of INK4a, such as JUNB and both ETS and RAS family
members (ETS2, ERG and NRAS), confirming the utility of this
approach (Table S1). Analysis of over-represented functional
classes among these candidates using Gene Ontology (GO)
analysis (GOstat (http://gostat.wehi.edu.au/)) revealed multiple
transcription factors and related categories, encompassing over 50
of the activating cDNAs (P,0.05; Table S2). These potential
INK4a-activating transcription factors include multiple members
of several growth-regulatory signal transduction pathways as
determined by the KEGG BRITE functional annotation
(http://www.genome.jp/kegg/tool/search_pathway.html). These
include MAPK and ErbB signaling, as well as associations with
various cancers, consistent with the known regulation of INK4a
transcriptional activity via pro-oncogenic signals (Table S3). The
only significantly over-represented GO category unrelated to
Figure 1. Transcriptional activators of INK4A identified by a functional genomics screening approach. (A) Screening strategy.
Numbering indicates portion of the INK4a regulatory region, relative to the natural translational start site, inserted into the pGL3 luciferase reporter.
Validation of the reporter was performed by cotransfection in U2OS cells under screening conditions. Mean luciferase values from four replicates are
shown; error bars represent one standard deviation. (B) Screen results. Luciferase values from duplicate wells were normalized by plate, transformed
and scaled to generate relative activity values (see Materials and Methods), then plotted according to rank.
doi:10.1371/journal.pone.0005067.g001
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0006898, P=0.03; Table S2), which, we hypothesize, reflects the
regulation of the INK4A locus by receptor-mediated extracellular
signals.
To validate these potential INK4a regulators, a subset of the top
activators was re-assayed in quadruplicate, and screened against
the promoterless luciferase reporter backbone (pGL3) to eliminate
nonspecific activators. Fourteen different cDNA clones showed
both reproducible activation over the empty cDNA library vector
control and at least two-fold activation of the INK4a reporter over
the pGL3 backbone (Fig. 2). Several homeobox-containing
transcription factors specifically activated INK4a in these assays
(LHX2, HOXA13, and MEOX2; Fig. 2) as well as in another
cDNA collection screened by the same protocol (HOXD8,
HOXA11; J. Irelan & K. Quon, unpublished data). The
homeobox superfamily is comprised of hundreds of transcription
factors known to regulate pattern formation in early development,
although roles for some members in adult tissues as well as in
oncogenesis have been described [15]. To determine their
potential roles in replicative senescence, we assessed the transcrip-
tional regulation of the homeobox genes identified in the reporter
screen by semiquantitative PCR during senescence in primary
human cells. Of these, only MEOX2 mRNA levels were seen to
increase concomitantly with INK4A during this process (Fig. 3a).
Furthermore, we observed that MEOX2 can activate the INK4a
reporter in a dosage-dependent manner (Fig. 3b). Taken together,
these results suggest that MEOX2 plays a role in the regulation of
INK4a transcription and cellular senescence.
Forced expression of MEOX2 induces senescence in
primary cells
MEOX2 (also known as GAX) overexpression has previously
been shown to induce a p21CIP1 dependent cell-cycle arrest in
vascular smooth muscle and vascular endothelial cells [16,17]. This
was demonstrated to occur through direct transcriptional activation
of p21CIP1 by MEOX2 [18]. To determine whether MEOX2 can
activate the senescence program in non-endothelial cell types, we
introduced retroviral particles expressing MEOX2 in several
primary human cell lines, including IMR90 lung fibroblasts, WI38
fibroblasts,andHEKnkeratinocytes.Eachofthese celltypesshowed
the hallmarks of accelerated senescence upon ectopic expression of
MEOX2 (Fig. 4, Fig. 5, and unpublished data). Specifically,
MEOX2 -expressing cells exhibited reduced proliferative capability
and progressive cell size increase, relative to cells transduced with
virus expressing enhanced green fluorescent protein (EGFP; Fig. 4
and unpublished data). Fibroblasts with forced MEOX2 expression
also harbored significantly higher senescence-associated Beta-
galactosidase activity, approaching the levelsobserved with activated
RAS (Fig 5). Finally, MEOX2 expression also led to an
accumulation of cells in the G1 phase of the cell cycle, and a
concomitant decrease of cells in S phase, consistent with cells
undergoing senescence(Fig. 5).Taken together,these results indicate
that expression of MEOX2 can induce senescence in a variety of
primary human cell types.
To determine the structural requirements for senescence
induction by MEOX2 overexpression, we introduced retroviral
particles expressing different functional domains of MEOX2 into
fibroblasts and subsequently assessed their effects on proliferative
capacity. Deletion of the amino terminus, including the acidic
histidine/glutamine rich domain in MEOX2, located between a.a.
63 and 85, did not affect the ability of the protein to induce
senescence in fibroblasts; in fact this construct was even more
active than the full-length construct (red vs. green line in Fig. 6),
suggesting that this domain is dispensible for MEOX2 function. In
contrast, none of the other constructs tested induced senescence.
The homoeodomain of MEOX2 is located within the region
corresponding to amino acids (a.a.) 186–248. Constructs lacking a
complete homeodomain (a.a. 1–185, or 1–221) did not affect
proliferation relative to the EGFP control, indicating that the
DNA binding activity of MEOX2 is necessary for induction of
senescence (black lines in Fig. 6). Similarly, a construct comprising
only the homeodomain and C-terminal sequences (a.a.170–303)
did not alter proliferative capacity, revealing that the homeodo-
main is not sufficient for senescence induction (Fig. 6). These data
are consistent with a mechanism for MEOX2-driven induction of
senescence that requires both DNA binding and transcriptional
activation, mediated by sequences between a.a. 85 and 186, in
addition to the homeodomain. Interestingly, it has been previously
demonstrated that the histidine/glutamine domain is essential for
the activation of p21CIP1 by MEOX2 in endothelial cells,
suggesting an alternate mechanism of transcriptional activation of
the INK4a promoter in fibroblasts [18]. We hypothesize that
transcriptional regulation by MEOX2 may involve interactions
with different coactivating proteins at the INK4a and p21CIP1
promoters, or with cell-type specific coregulators.
MEOX2 activates INK4a expression to induce senescence
We next tested whether MEOX2 overexpression resulted in
increased INK4a expression. Western blotting revealed that
Figure 2. Confirmation of 14 INK4a activators. Results from four
independent cotranfections of the indicated reporter with the indicated
cDNA construct into U2OS cells are shown. Fold activation values were
calculated for each experiment by normalizing luciferase levels of the
indicated cDNA to the empty vector control (indicated as Vector). These
values were then ranked by ratio of activation of the INK4a construct to
activation of the empty luciferase reporter vector pGL3. Activators with
relative activation values of two or more are shown. Homeodomain
family members are in bold; error bars represent one standard
deviation.
doi:10.1371/journal.pone.0005067.g002
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overexpression in fibroblasts, comparable to levels after expression
of an activated form of RAS (Fig. 7a). p21CIP1 is the CDK
inhibitor responsible for senescence induced by the ARF-p53
pathway, and has been implicated in MEOX2 overexpression-
induced senescence in endothelial cells [16]. However, we
observed only a modest increase in p21 levels in MEOX2-
expressing fibroblasts (17%), suggesting that senescence induction
likely occurs primarily through the INK4a-RB pathway (Fig 7a).
To determine whether MEOX2 binds to the INK4a promoter
directly, we conducted chromatin immunoprecipitation experi-
ments on cells overexpressing HA-tagged MEOX2 (Fig 7b).
Immunoprecipitation of MEOX2-HA strongly enriched for
sequences located within the INK4a promoter region, but not
control sequences located in GAPDH or 5 kb upstream of INK4a,
indicating that MEOX2 binds to the INK4a promoter. Taken
together, these results indicate that MEOX2 likely activates
INK4a transcription by directly binding to the INK4a promoter.
Finally, we tested whether MEOX2 induction of senescence in
human fibroblasts requires p16INK4a. We utilized a pair of
human diploid fibroblast cell lines isolated from individuals that
are either heterozygous or homozygous mutant for an allele of
CDKN2A that is linked to familial melanoma. This allele
produces a nonfunctional form of p16INK4a and a product that
retains functional ARF activity [19]. The ectopic expression of
MEOX2 reduced proliferative capacity of the heterozygous
control cells, but not the homozygous p16INK4a-deficient cells
(Fig. 8), indicating that the activity of the INK4a pathway is
required for MEOX2 mediated induction of senescence in human
diploid fibroblasts.
Genome-scale functional screens have the potential to identify
novel biological regulators, and to assign novel function to known
regulators. Here we have identified a number of potential
regulators of INK4a transcription, of which 14 were confirmed
for activity and investigated further. One of these candidates was
MEOX2, a diverged homeobox family member normally
expressed in muscle precursor cells where it has a role in
embryonic limb muscle development [20]. In adults, expression is
largely limited to cardiovascular tissues. MEOX2 was originally
identified as GAX (Growth Arrest Specific Homeobox), since it is
upregulated during endothelial cell activation in an injury healing
model, implicating a specialized and dynamic role for cell cycle
regulation by this homeodomain protein in adult tissues [16]. In
addition, MEOX2 has been suggested to play a role in the
maintenance of normal brain vasculature in the context of
Alzheimer’s disease progression [21].
Here, we demonstrate a role for MEOX2 as a regulator of
senescence in human keratinocytes and fibroblasts. Specifically,
the transcription of this homeodomain protein is induced during
the onset of cellular senescence in keratinocytes. Furthermore, we
domonstrate that MEOX2 can directly activate INK4a transcrip-
tion, resulting in the induction of senescence in fibroblasts.
Interestingly, MEOX2 has been shown to also induce a cell cycle
arrest in mouse endothelial cells in a p21CIP1-dependent manner.
Structure-function analyses support distinct mechanisms for the
Figure 3. MEOX2 is a regulator of senescence in human cells. (A) MEOX2 is upregulated during senescence. Results of semiquantitative RT-
PCR analysis on mRNA derived from primary human keratinocytes at the indicated number of population doublings are shown. (B) Dose-response for
p16INK4a reporter activation by MEOX2. Results are shown from three independent cotranfections of U2OS with the indicated reporter and cDNA
constructs as in Fig. 2. Error bars represent one standard deviation; p53 serves as a negative control.
doi:10.1371/journal.pone.0005067.g003
Figure 4. MEOX2 reduces proliferative capacity of primary
human fibroblasts. Early passage WI38 fibroblasts were infected with
retroviral particles expressing the indicated cDNAs, selected on
puromycin, and assessed for proliferative capacity by periodic
trypsinization and cell counting.
doi:10.1371/journal.pone.0005067.g004
MEOX2 Regulates INK4a
PLoS ONE | www.plosone.org 4 April 2009 | Volume 4 | Issue 4 | e5067regulation of p16INK4a and p21CIP1 in these cell types.
Moreover, these differences may reflect the relatively greater
importance of the ARF-p53-p21CIP1 axis over the INK4a-RB
axis in senescence induction in mouse versus human cell types.
Intriguingly, MEOX2 has recently been shown to be aberrantly
methylated in non-small cell lung carcinoma, consistent with a
tumor suppressor function for this homeodomain protein [22].
Taken together, these results suggest a regulatory role for MEOX2
in the INK4a-RB pathway for tumor surveillance in adult tissues.
Materials and Methods
Cell culture and analysis
Human diploid fibroblasts WI38, IMR90, Leiden, and Foo3
were grown on DMEM with 10% heat inactivated FCS and Pen/
Strep/Glut (GIBCO #119665, 26170-43, 10378-16); Human
neonatal keratinocytes (HEKn) were grown on Epilife or M154
supplemented with HKGS (Cascade Biologics C-001-5C, M-EPI-
500-CA, M-154-500, and S100-5). Senescence-associated Beta-
galactosidase activity was assayed with Cell Signaling staining kit
(#9860). Cells were imaged at room temperature in PBS on a
Nikon TE2000-U at 406 magnification, 0.13 N.A. Images were
acquired with a Photometrics CoolSNAP HQ2, using Nikon
ACT-1C software. FACS analyses were performed on ethanol-
fixed cells stained with propidium iodide on a BD LSRII and the
data were analyzed using FlowJo software.
cDNA overexpression screen
U2OS osteosarcoma cells were reverse- transfected at a density
of 4000 cells per well in 384-well plates that had been prespotted
with 62 ng of Origene Trueclone library or control cDNA, along
with 60 ng (pGL3-INK4a) reporter and a 3:1 ratio of volume (ul)
Fugene 6 transfection reagent (Roche #1 988 484) to total ug
DNA as per manufacturer’s instructions. After 48 h incubation,
total luciferase activity was assessed by Bright-Glo (Promega
#E2620). Raw luciferase values for each well were obtained
(Acquest, LJL Biosystems) and normalized to their respective plate
median values, then averaged to produce an average fold
activation (‘‘afa’’) score. Each cDNA was ranked by afa score;
the top 285 annotated activators are shown (Table S1). For
reconfirmation, a set of 96 cDNAs chosen from among the top afa
scores was re-assayed in quadruplicate, and raw luciferase values
were normalized to empty vector controls.
RT-PCR expression filter
mRNA from primary neonatal human keratinocytes (HEKn;
Cascade Biologics) was isolated by RNeasy isolation kit (Qiagen
#740104) and reverse transcribed into cDNA by the Thermo-
Script RT-PCR system (Invitrogen #11146-024) according to the
manufacturers instructions. PCR was carried out using Platinum
PCR supermix at 20, 25, and 30 cycles each consisting of 2 minute
extension and 30 second 50 C annealing (gapdh) temperatures
with the following primers: GAPDH – 59-TCCCATCAC-
CATCTTCCAG-39 and 59-ATGAGTCCTTCCACGATACC-
39; p16 (INK4a) - 59-CAACGCACCGAATAGTACG and 59-
TTCTTTCAATCGGGGATGTC-39; MEOX2 - 59-GGAAA-
AGCGACAGCTCAGAC-39 and 59-AATTCCCGACAGCTC-
TGATG-39.
Chromatin Immunoprecipitation and Western Blotting
Chromatin Immunoprecipitations were carried out with the EZ
ChIP (Upstate #17-371) kit using the manufacturer’s instructions.
Optimal chromatin shearing was obtained using 6 repetitions of
10 second sonications at 30% max on a Sonics Vibracell sonicator.
For PCR amplifications, 2 ul of immunoprecipitated sample or
1 ul of input chromatin was incubated at 94 C for 5 minutes,
followed by addition of 23 ul of Platinum PCR supermix
(Invitrogen #10790-020) with each primer at 400 nM. 37 and
Figure 5. MEOX2 induces senescence phenotypes in primary human fibroblasts. Senescence-associated beta-galactosidase assays were
performed on day 13 postselection. FACS analysis reveals accumulation of cells in the G1 phase of the cell cycle in response to MEOX2 expression.
doi:10.1371/journal.pone.0005067.g005
MEOX2 Regulates INK4a
PLoS ONE | www.plosone.org 5 April 2009 | Volume 4 | Issue 4 | e5067Figure 7. MEOX2 induces senescence through transcriptional activation of p16INK4a. (A) MEOX2 activates p16INK4a expression.
Fibroblasts infected with retroviral constructs expressing the indicated cDNA (top) were harvested 9 days postinfection, and whole cell extracts
assayed by western blot with the indicated antibodies (left). Bid serves as a loading control. Band intensities relative to the EGFP control are indicated.
(B) MEOX2 binds to the p16INK4a promoter. Fibroblasts stably infected with a retroviral construct expressing hemagglutinin (HA)-tagged MEOX2
were harvested 15 days postinfection and subjected to chromatin immunoprecipitation with HA, PolII, or preimmune IgG antibodies. The resulting
chromatin was assayed for enrichment of the indicated sequences by semiquantitative PCR with increasing cycle numbers. Band intensities relative to
the input are indicated for the higher PCR cycle number; (0) indicates values at or below background intensity. The p16 primers amplified a fragment
located 970 to 621 bp upstream of the INK4a ATG site, which is selectively enriched by MEOX2-HA immunoprecipitation. GAPDH and an amplicon
located 5 kilobases upstream of the INK4a coding sequence (‘‘p16 upstr’’) serve as controls.
doi:10.1371/journal.pone.0005067.g007
Figure 6. Structure/function analysis of the histidine/glutamine (H/Q) rich and homeobox domains of MEOX2. Retroviral constructs
expressing the fragments of MEOX2 indicated by bars in the schematic (top panel) were assessed for induction of senescence as in Fig. 4. Results of
three independent infections are depicted as mean values; error bars represent one standard deviation. Senescence-inducing constructs are shown in
color.
doi:10.1371/journal.pone.0005067.g006
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annealing at 48 C (p16, p16upstr) or 55 C (GAPDH). Primer
sequences used for amplification are as follows: GAPDH - 59-
TCCCATCACCATCTTCCAG-39 and 59-ATGAGTCCTTC-
CACGATACC-39; p16 – 59-TACGACTAGAAAGTGTCCC-
CCTAC-39 and 59-TAGAACACTGAGCACTTTTTCTGG-39;
p16upst 59-TAACCACAAGTGTGGCAAAAAG-39 and 59-
GGAATAGAATTGCTGAGTCAAAGG-39. The following anti-
bodies were used for immunoprecipitaion and western blotting:
p16INK4a (EMD biosciences #NA29), P21CIP1 (Santa Cruz
Biotehnology # sc-56337), Bid (BD Biosciences #559681) and
HA (Covance #MMS-101P). Results were scanned on a
AlphaImager (Alpha Innotech), and mean pixel intensities in
equivalent areas bounding each band were background corrected
and quantified with ImageJ software (NIH).
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